Share ownership Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 08:01:03 13/05/2026 BST			5-day change	1st Jan Change
300.45 ^DKK	+1.33%		+3.71%	-8.84%

07:47am	NOVO NORDISK : Jefferies reaffirms its Neutral rating	ZD
07:27am	Novo Nordisk: Oral Wegovy yields over 21 percent weight loss in clinical trial	FW

Share class: Novo Nordisk A/S

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	10	1,075,000,000	0	0	71.44 %
Stock B	1	3,390,000,000	3,189,857,691 ( 94.1 %)	26,552,791 ( 0.7833 %)

Major shareholders: Novo Nordisk A/S

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 5.238 %	177,560,500	5.238 %	7 589 M kr
NOVO NORDISK A/S 0.7444 %	25,237,791	0.7444 %	1 079 M kr
The Vanguard Group, Inc. 0.6919 %	23,457,886	0.6919 %	1 003 M kr
SEB Funds AB 0.2353 %	7,978,192	0.2353 %	341 M kr
Nykredit Bank A/S (Investment Management) 0.1651 %	5,598,160	0.1651 %	239 M kr
ODIN Forvaltning AS 0.1417 %	4,802,672	0.1417 %	205 M kr
Sjunde AP-fonden 0.1398 %	4,738,475	0.1398 %	203 M kr
State Street Global Advisors Ltd. 0.131 %	4,442,486	0.131 %	190 M kr
Nordea Investment Management AB 0.1259 %	4,267,282	0.1259 %	182 M kr
Eika Kapitalforvaltning AS 0.0844 %	2,861,072	0.0844 %	122 M kr
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Bank of America Merrill Lynch Banco Multiplo SA 0.000131 %	35,400	0.000131 %	188 993 kr
Caixa DTVM SA 0.000011 %	2,870	0.000011 %	15 322 kr

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 100 %	1,074,872,000	100 %	45 939 M kr
Anima Sgr SpA 0.0108 %	115,783	0.0108 %	5 M kr
Russell Investments Ltd. 0.000038 %	405	0.000038 %	17 309 kr

Name	Equities	%	Valuation
Loomis, Sayles & Co. LP 0.5054 %	17,135,384	0.5054 %	723 M kr
Fiduciary Trust Company International 0.4337 %	14,702,508	0.4337 %	621 M kr
Eaton Vance Management 0.3788 %	12,842,089	0.3788 %	542 M kr
Merrill Lynch International 0.3501 %	11,868,129	0.3501 %	501 M kr
Capital Research & Management Co. (International Investors) 0.3307 %	11,211,106	0.3307 %	473 M kr
Goldman Sachs Wealth Services LP 0.3242 %	10,991,430	0.3242 %	464 M kr
Folketrygdfondet 0.2998 %	10,164,137	0.2998 %	429 M kr
Fidelity Management & Research Co. LLC 0.2955 %	10,017,325	0.2955 %	423 M kr
T. Rowe Price International Ltd. 0.2858 %	9,688,262	0.2858 %	409 M kr
Fisher Asset Management LLC 0.2661 %	9,021,103	0.2661 %	381 M kr
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	48.16%
Other	1.47%
Novo Nordisk A/S	0.74%
State Street Corp.	0.18%
Markel Group, Inc.	0.08%
Cullen/Frost Bankers, Inc.	0.01%
Menora Mivtachim Holdings Ltd.	0.01%
Banco Bilbao Vizcaya Argentaria SA	0.01%
SEI Investments Co.	0.01%
Analyst I.M.S. Investment Management Services Ltd.	0.01%
Unknown	49.32%

Based on 1000 largest holdings

Geographical origin of shareholders

Denmark	37.95%
United States	7.91%
United Kingdom	1.19%
Norway	0.73%
Sweden	0.67%
Canada	0.47%
Germany	0.25%
Spain	0.19%
Belgium	0.15%
Switzerland	0.14%
France	0.14%
Netherlands	0.14%
Ireland	0.11%
Luxembourg	0.1%
Finland	0.08%
Cayman Islands	0.08%
Australia	0.06%
Italy	0.06%
Austria	0.04%
New Zealand	0.03%
Israel	0.03%
South Africa	0.02%
Japan	0.02%
Singapore	0.02%
Hong Kong	0.02%
Mexico	0.01%
Portugal	0.01%
Bermuda	0.01%
Liechtenstein	0.01%
Iceland	0.01%
Puerto Rico	0.01%

Based on 1000 largest holdings

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.7%); - rare disease treatment products (6.3%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe and Canada (21.4%), the United States (56%), Latin America/Middle East/Africa (9.9%), China/Hong Kong/Taiwan (6%), Asia/Pacific (6.7%).

Employees

67,900

Sector

Pharmaceuticals

Calendar

Earnings release - Q2 2026

More about the company